LAMATTINA JOHN L - Insider Non-Derivative Transactions at LIGAND PHARMACEUTICALS INC (LGND) - (SEC)

Updated on January 3, 2026.

According to recent SEC insider information filed on Nov 7, 2025, LAMATTINA JOHN L's relationship to LIGAND PHARMACEUTICALS INC (LGND) is Director, and currently has 32,869 shares of Common Stock.

The chart below shows the number of shares owned, and the table shows the recent insider transactions.

You can see similar information for other LGND insiders.

Related Topics: SEC Topic List.

Data Source: SEC.

LAMATTINA JOHN L - Insider Non-Derivative Transactions of LGND Common Stock

LAMATTINA JOHN L - Insider Non-Derivative Transactions at LGND

Items per page:

0 of 0

Date	Transaction	No. of Shares	Price Per Share	Shares Owned After Transactions
Nov 8, 2025	Sell -- (Common Stock)	2034	205.45	30724
Nov 8, 2025	Sell -- (Common Stock)	2145	205.45	30724
Nov 8, 2025	M -- (Common Stock)	2034	69.51	32758
Nov 8, 2025	M -- (Common Stock)	2145	66.13	32869
Jun 7, 2025	Acquisition -- (Common Stock)	1209	0	30724
Nov 28, 2024	Sell -- (Common Stock)	2406	123.65	29515
Nov 28, 2024	M -- (Common Stock)	2406	52.3	31921
Jun 15, 2024	Acquisition -- (Common Stock)	1252	0	29515
Jun 10, 2023	Acquisition -- (Common Stock)	1142	0	28263